Food-advanced glycation end products aggravate the diabetic vascular complications via modulating the AGEs/RAGE pathway (Q88899708)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27914528%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

title

Food-advanced glycation end products aggravate the diabetic vascular complications via modulating the AGEs/RAGE pathway (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27914528%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

author name string

Xing Lv

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27914528%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Gao-Hong Lv

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27914528%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Guo-Ying Dai

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27914528%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Hong-Mei Sun

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27914528%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Hui-Qin Xu

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27914528%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

publication date

1 November 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27914528%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27914528%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27914528%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

page(s)

844-855

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27914528%20AND%20SRC:MED&resulttype=core&format=json

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

28 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1875-5364%2816%2930101-7

7 January 2021

Microvascular complications of diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1875-5364%2816%2930101-7

7 January 2021

Diabetes and atherosclerosis: epidemiology, pathophysiology, and management

1 reference

https://api.crossref.org/works/10.1016%2FS1875-5364%2816%2930101-7

7 January 2021

Mortality within the first 10 years of the disease in type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1875-5364%2816%2930101-7

7 January 2021

Molecular pathology of oxidative stress in diabetic angiopathy: role of mitochondrial and cellular pathways

1 reference

https://api.crossref.org/works/10.1016%2FS1875-5364%2816%2930101-7

7 January 2021

The cardiorenal syndrome in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1875-5364%2816%2930101-7

7 January 2021

Increasing cardiovascular disease burden due to diabetes mellitus: the Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FS1875-5364%2816%2930101-7

7 January 2021

Oxidative stress and diabetic complications

1 reference

https://api.crossref.org/works/10.1016%2FS1875-5364%2816%2930101-7

7 January 2021

Clinical review: The role of advanced glycation end products in progression and complications of diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1875-5364%2816%2930101-7

7 January 2021

Mechanisms of disease: advanced glycation end-products and their receptor in inflammation and diabetes complications

1 reference

https://api.crossref.org/works/10.1016%2FS1875-5364%2816%2930101-7

7 January 2021

Advanced glycation end-products: a review

1 reference

https://api.crossref.org/works/10.1016%2FS1875-5364%2816%2930101-7

7 January 2021

Serum levels of advanced glycation end products are increased in patients with type 2 diabetes and coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS1875-5364%2816%2930101-7

7 January 2021

Higher plasma levels of advanced glycation end products are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12-year follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS1875-5364%2816%2930101-7

7 January 2021

High serum pentosidine concentrations are associated with increased arterial stiffness and thickness in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1875-5364%2816%2930101-7

7 January 2021

Effect of limited solid-state glycation on the conformation of lysozyme by ESI-MSMS peptide mapping and molecular modeling

1 reference

https://api.crossref.org/works/10.1016%2FS1875-5364%2816%2930101-7

7 January 2021

Increased accumulation of the glycoxidation product Nepsilon-(carboxymethyl)lysine in hearts of diabetic patients: generation and characterisation of a monoclonal anti-CML antibody

1 reference

https://api.crossref.org/works/10.1016%2FS1875-5364%2816%2930101-7

7 January 2021

Nonenzymatic glycation and extractability of collagen in human atherosclerotic plaques.

1 reference

https://api.crossref.org/works/10.1016%2FS1875-5364%2816%2930101-7

7 January 2021

Relationship between the expression of advanced glycation end-products (AGE) and the receptor for AGE (RAGE) mRNA in diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1875-5364%2816%2930101-7

7 January 2021

Role of AGEs in diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1875-5364%2816%2930101-7

7 January 2021

Glucose, glycation, and RAGE: implications for amplification of cellular dysfunction in diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1875-5364%2816%2930101-7

7 January 2021

Understanding RAGE, the receptor for advanced glycation end products

1 reference

https://api.crossref.org/works/10.1016%2FS1875-5364%2816%2930101-7

7 January 2021

Cellular receptors for advanced glycation end products. Implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions.

1 reference

https://api.crossref.org/works/10.1016%2FS1875-5364%2816%2930101-7

7 January 2021

Interactions between advanced glycation end-products (AGE) and their receptors in the development and progression of diabetic nephropathy - are these receptors valid therapeutic targets.

1 reference

https://api.crossref.org/works/10.1016%2FS1875-5364%2816%2930101-7

7 January 2021

Biochemistry and molecular cell biology of diabetic complications

1 reference

https://api.crossref.org/works/10.1016%2FS1875-5364%2816%2930101-7

7 January 2021

An adenosine kinase inhibitor attenuates tactile allodynia in a rat model of diabetic neuropathic pain

1 reference

https://api.crossref.org/works/10.1016%2FS1875-5364%2816%2930101-7

7 January 2021

Proposal open for discussion: defining agreed diagnostic procedures in experimental diabetes research

1 reference

https://api.crossref.org/works/10.1016%2FS1875-5364%2816%2930101-7

7 January 2021

Modulation of the cellular expression of circulating advanced glycation end-product receptors in type 2 diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1875-5364%2816%2930101-7

7 January 2021

Hyperglycemia-induced GLP-1R downregulation causes RPE cell apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1875-5364%2816%2930101-7

7 January 2021

Advanced glycation end products in foods and a practical guide to their reduction in the diet

1 reference

https://api.crossref.org/works/10.1016%2FS1875-5364%2816%2930101-7

7 January 2021

The role of advanced glycation end products in retinal ageing and disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1875-5364%2816%2930101-7

7 January 2021

Advanced glycation end products and their circulating receptors predict cardiovascular disease mortality in older community-dwelling women

1 reference

https://api.crossref.org/works/10.1016%2FS1875-5364%2816%2930101-7

7 January 2021

Serum carboxymethyl-lysine, an advanced glycation end product, is associated with increased aortic pulse wave velocity in adults

1 reference

https://api.crossref.org/works/10.1016%2FS1875-5364%2816%2930101-7

7 January 2021

Receptor for Advanced Glycation Endproducts (RAGE): A Formidable Force in the Pathogenesis of the Cardiovascular Complications of Diabetes & Aging

1 reference

https://api.crossref.org/works/10.1016%2FS1875-5364%2816%2930101-7

7 January 2021

Genotoxicity of streptozotocin

1 reference

https://api.crossref.org/works/10.1016%2FS1875-5364%2816%2930101-7

7 January 2021

Analysis of urinary albumin, transferrin, N-acetyl-beta-D-glucosaminidase and beta2-microglobulin in patients with impaired glucose tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS1875-5364%2816%2930101-7

7 January 2021

Biomarkers for early diagnosis of type 2 diabetic nephropathy: a study based on an integrated biomarker system

1 reference

https://api.crossref.org/works/10.1016%2FS1875-5364%2816%2930101-7

7 January 2021

Inflammatory markers of coronary risk

1 reference

https://api.crossref.org/works/10.1016%2FS1875-5364%2816%2930101-7

7 January 2021

Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1875-5364%2816%2930101-7

7 January 2021

Plasma interleukin-6 levels are independently associated with insulin secretion in a cohort of Italian-Caucasian nondiabetic subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS1875-5364%2816%2930101-7

7 January 2021

Insulin/IGF-1 and TNF-alpha stimulate phosphorylation of IRS-1 at inhibitory Ser307 via distinct pathways

1 reference

https://api.crossref.org/works/10.1016%2FS1875-5364%2816%2930101-7

7 January 2021

Antioxidants and vitamins to reduce cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS1875-5364%2816%2930101-7

7 January 2021

Vitamin E, oxidative stress, and inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1875-5364%2816%2930101-7

7 January 2021

Effects of tumor necrosis factor-alpha on insulin action in cultured human muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS1875-5364%2816%2930101-7

7 January 2021

The expression of TNF alpha by human muscle. Relationship to insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1875-5364%2816%2930101-7

7 January 2021

C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS1875-5364%2816%2930101-7

7 January 2021

C-reactive protein: risk marker or mediator in atherothrombosis?

1 reference

https://api.crossref.org/works/10.1016%2FS1875-5364%2816%2930101-7

7 January 2021

C-reactive protein: a critical update

1 reference

https://api.crossref.org/works/10.1016%2FS1875-5364%2816%2930101-7

7 January 2021

Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events

1 reference

https://api.crossref.org/works/10.1016%2FS1875-5364%2816%2930101-7

7 January 2021

C-reactive protein and atherothrombosis—Beyond a biomarker: an actual partaker of lesion formation

1 reference

https://api.crossref.org/works/10.1016%2FS1875-5364%2816%2930101-7

7 January 2021

Compensatory enlargement of human atherosclerotic coronary arteries

1 reference

https://api.crossref.org/works/10.1016%2FS1875-5364%2816%2930101-7

7 January 2021

Role of inflammation in diabetic complications

1 reference

https://api.crossref.org/works/10.1016%2FS1875-5364%2816%2930101-7

7 January 2021

Advanced glycation endproduct (AGE) receptor 1 is a negative regulator of the inflammatory response to AGE in mesangial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1875-5364%2816%2930101-7

7 January 2021

Activation of the sphingosine kinase-signaling pathway by high glucose mediates the proinflammatory phenotype of endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1875-5364%2816%2930101-7

7 January 2021

Metabolic syndrome and diabetic atherothrombosis: implications in vascular complications

1 reference

https://api.crossref.org/works/10.1016%2FS1875-5364%2816%2930101-7

7 January 2021

Oxidative stress and stress signaling: menace of diabetic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1875-5364%2816%2930101-7

7 January 2021

Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1875-5364%2816%2930101-7

7 January 2021

10.1016/S1875-5364(16)30101-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27914528%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

1 reference